UA81654C2 - Hiv replication inhibiting pyrimidines and triazines - Google Patents

Hiv replication inhibiting pyrimidines and triazines

Info

Publication number
UA81654C2
UA81654C2 UAA200508325A UA2005008325A UA81654C2 UA 81654 C2 UA81654 C2 UA 81654C2 UA A200508325 A UAA200508325 A UA A200508325A UA 2005008325 A UA2005008325 A UA 2005008325A UA 81654 C2 UA81654 C2 UA 81654C2
Authority
UA
Ukraine
Prior art keywords
triazines
hiv replication
replication inhibiting
inhibiting pyrimidines
pyrimidines
Prior art date
Application number
UAA200508325A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Жером Эмиль Жорж Жильмон
Элизабет Тереза Жанна Паскье
Ян Хеерес
Курт Хертогс
Ева Беттенс
Паулус Йоаннес Леви
Йонге Марк Рене де
Люсьен Мария Хенрикус Койманс
Фредерик Франс Дезире Дейерт
Хендрик Маартен Винкерс
Рафаэль Адриаан Ян Янссен (умер)
Original Assignee
Тиботек Фармасьютикелз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиботек Фармасьютикелз Лтд. filed Critical Тиботек Фармасьютикелз Лтд.
Priority claimed from PCT/EP2004/050175 external-priority patent/WO2004074261A1/en
Publication of UA81654C2 publication Critical patent/UA81654C2/en

Links

Abstract

This invention concerns IIIV replication inhibitors of formula (I), the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.(I)
UAA200508325A 2003-06-02 2004-02-20 Hiv replication inhibiting pyrimidines and triazines UA81654C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47501203P 2003-06-02 2003-06-02
PCT/EP2004/050175 WO2004074261A1 (en) 2003-02-20 2004-02-20 Hiv replication inhibiting pyrimidines and triazines

Publications (1)

Publication Number Publication Date
UA81654C2 true UA81654C2 (en) 2008-01-25

Family

ID=39228680

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200508361A UA81292C2 (en) 2003-06-02 2004-02-20 Hiv replication inhibiting pyrimidines and triazines
UAA200508325A UA81654C2 (en) 2003-06-02 2004-02-20 Hiv replication inhibiting pyrimidines and triazines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200508361A UA81292C2 (en) 2003-06-02 2004-02-20 Hiv replication inhibiting pyrimidines and triazines

Country Status (1)

Country Link
UA (2) UA81292C2 (en)

Also Published As

Publication number Publication date
UA81292C2 (en) 2007-12-25

Similar Documents

Publication Publication Date Title
MXPA05008866A (en) Hiv replication inhibiting pyrimidines and triazines.
WO2001085700A3 (en) Hiv replication inhibiting pyrimidines and triazines
MY141739A (en) Substituted quinazoline derivatives as inhibitors of aurora kinases
MXPA05008368A (en) Hiv inhibiting 1,2,4-triazines.
AU2003296993A8 (en) Cyclopropyl compounds as ccr5 antagonists
TW200518758A (en) HIV replication inhibiting purine derivatives
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
NO20052739L (en) CCR5 antagonists as drugs
MXPA03010207A (en) Novel 4-anilinoquinoline-3-carboxamides.
AU2003297048A8 (en) Cyclohexyl compounds as ccr5 antagonists
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
PL1858861T3 (en) Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
CA2437785A1 (en) Hiv inhibiting pyrazinone derivatives
UA81654C2 (en) Hiv replication inhibiting pyrimidines and triazines
MX2022012881A (en) Inhibitors of human immunodeficiency virus replication.
MX2020009711A (en) Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination.
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
MXPA05011671A (en) Novel aniline derivatives, their manufacture and use as pharmaceutical agents.
TW200701980A (en) Benzylether derivatives, their manufacture and use as pharmaceutical agents
UA99131C2 (en) N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions